后 COVID-19 时代的肿瘤外科学：下一步是什么？
Surgical oncology during the post-COVID-19 era: What is next?
机构信息
Department of Surgery, School of Health Sciences, University Hospital of Ioannina and Faculty of Medicine, University of Ioannina, Ioannina, Greece.
First Propaedeutic Department of Surgery, National and Kapodistrian University of Athens, Hippocration General Hospital, Athens, Greece.
出版信息
J Surg Oncol. 2023 Jan;127(1):7-10. doi: 10.1002/jso.27104. Epub 2022 Sep 21.
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.
在 COVID-19 首次爆发期间，已经采取了多种策略来降低 COVID-19 对肿瘤外科患者的传播风险。COVID-19 感染似乎会影响肿瘤外科患者的生存和主要并发症发生率。但是，肿瘤外科患者的生存、肿瘤进展和复发率与 COVID-19 大流行对其管理的影响有关。此外，COVID-19 感染的严重程度已经降低。因此，需要重新考虑肿瘤外科患者的管理。
Zotero 插件